Drug intelligence / Profile preview

N-{[(2S,3S)-3-(Ethoxycarbonyl)-2-oxiranyl]carbonyl}-L-threonyl-L-isoleucine

Development stage
Unknown
Modality
Peptides, Small Molecules
01

Overview

N-{[(2S,3S)-3-(Ethoxycarbonyl)-2-oxiranyl]carbonyl}-L-threonyl-L-isoleucine is a synthetic small molecule peptide composed of L-threonine and L-isoleucine residues linked to an epoxide-containing ethoxycarbonyl group. It belongs to the class of organic compounds known as peptides and has a molecular formula of C16H26N2O8 with a monoisotopic mass of approximately 374.17 Da[2][6][10]. There is no evidence that this compound has been approved for clinical use or entered advanced stages of drug development; it appears in chemical databases as an experimental or research compound with no reported pharmacological mechanism, clinical indication, or developer[9]. Its structure suggests potential utility in biochemical research or as a tool compound but not as an established pharmaceutical agent.

Other names
N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-THREONYL-L-ISOLEUCINEQ27095321Q-27095321Q 27095321

Beyond the preview

Go deeper on N-{[(2S,3S)-3-(Ethoxycarbonyl)-2-oxiranyl]carbonyl}-L-threonyl-L-isoleucine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-{[(2S,3S)-3-(Ethoxycarbonyl)-2-oxiranyl]carbonyl}-L-threonyl-L-isoleucine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call